MetLife Inc. (MET) reported fourth-quarter 2025 results with mixed performance across top-line growth and profitability metrics.
Cash flow and balance-sheet highlights:
Results versus consensus: revenue came in below the estimate of $28.0 billion, and diluted EPS of $1.17 trailed the estimate of $2.37, underscoring pressure on profitability despite year-over-year revenue growth.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
MetLife Inc. Hedge Fund Activity
We have seen 605 institutional investors add shares of MetLife Inc. stock to their portfolio, and 671 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 7,805,814 shares (+12.1%) to their portfolio in Q4 2025, for an estimated $616,190,957
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 4,849,790 shares (+91.5%) to their portfolio in Q3 2025, for an estimated $399,477,202
- BANK OF NEW YORK MELLON CORP removed 3,165,074 shares (-39.0%) from their portfolio in Q3 2025, for an estimated $260,707,145
- AQR CAPITAL MANAGEMENT LLC added 1,695,563 shares (+105.3%) to their portfolio in Q3 2025, for an estimated $139,663,524
- THRIVENT FINANCIAL FOR LUTHERANS added 1,138,688 shares (+3013.9%) to their portfolio in Q3 2025, for an estimated $93,793,730
- BLACKROCK, INC. added 1,041,073 shares (+2.2%) to their portfolio in Q3 2025, for an estimated $85,753,183
- FIRST TRUST ADVISORS LP added 1,040,894 shares (+173.4%) to their portfolio in Q3 2025, for an estimated $85,738,438
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MetLife Inc. Government Contracts
We have seen $3,299,725 of award payments to $MET over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- HEALTH AND LIFE INSURANCE: $1,837,508
- HEALTH AND LIFE INSURANCE: $1,462,217
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
MetLife Inc. Congressional Stock Trading
Members of Congress have traded $MET stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MET stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 08/06.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
MetLife Inc. Analyst Ratings
Wall Street analysts have issued reports on $MET in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keefe, Bruyette & Woods issued a "Outperform" rating on 11/11/2025
- Wells Fargo issued a "Overweight" rating on 11/07/2025
- UBS issued a "Buy" rating on 11/06/2025
- Morgan Stanley issued a "Overweight" rating on 10/07/2025
- Jefferies issued a "Buy" rating on 08/11/2025
To track analyst ratings and price targets for MetLife Inc., check out Quiver Quantitative's $MET forecast page.
MetLife Inc. Price Targets
Multiple analysts have issued price targets for $MET recently. We have seen 9 analysts offer price targets for $MET in the last 6 months, with a median target of $97.0.
Here are some recent targets:
- Elyse Greenspan from Wells Fargo set a target price of $97.0 on 01/13/2026
- Brian Meredith from UBS set a target price of $94.0 on 01/08/2026
- Yaron Kinar from Mizuho set a target price of $101.0 on 12/16/2025
- Ryan Krueger from Keefe, Bruyette & Woods set a target price of $90.0 on 11/11/2025
- Alex Scott from Barclays set a target price of $98.0 on 10/08/2025
- Nigel Dally from Morgan Stanley set a target price of $97.0 on 10/07/2025
- John Barnidge from Piper Sandler set a target price of $84.0 on 09/19/2025
